About this document
Fimmu 15 1380694 by 24000707 is a document available to read on EtoBox.
This research focuses on the isolation and characterization of chimeric heavy chain antibodies that neutralize botulinum neurotoxin type B (BoNT/B). The study identifies three specific nanobodies (B5-hFc, B9-hFc, and B12-hFc) with high affinity and potent neutralizing activity against BoNT/B, suggesting their potential as therapeutic agents for botulism. The findings indicate that these antibodies could serve as effective candidates for drug development aimed at preventing and treating botulism.
- Author
- 24000707
- Language
- EN